Redhawk Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,079
Closed -$1.32M 198
2022
Q3
$1.32M Buy
7,079
+7
+0.1% +$1.48K 0.56% 36
2022
Q2
$1.15M Buy
7,072
+121
+2% +$19.1K 0.52% 41
2022
Q1
$1.31M Buy
6,951
+2,150
+45% +$408K 0.35% 55
2021
Q4
$1.27M Buy
4,801
+375
+8% +$101K 0.32% 66
2021
Q3
$1.28M Buy
4,426
+78
+2% +$20K 0.35% 63
2021
Q2
$868K Buy
4,348
+458
+12% +$88.8K 0.19% 107
2021
Q1
$756K Buy
3,890
+130
+3% +$26.7K 0.19% 104
2020
Q4
$721K Buy
3,760
+226
+6% +$41.1K 0.18% 95
2020
Q3
$521K Buy
3,534
+79
+2% +$11.3K 0.15% 121
2020
Q2
$427K Sell
3,455
-1,485
-30% -$175K 0.15% 112
2020
Q1
$477K Sell
4,940
-825
-14% -$79.6K 0.21% 79
2019
Q4
$533K Sell
5,765
-61
-1% -$5.12K 0.2% 82
2019
Q3
$447K Buy
5,826
+456
+8% +$39.9K 0.19% 80
2019
Q2
$462K Buy
+5,370
New +$366K 0.18% 86

Other funds holding RGEN

Redhawk Wealth Advisors's RGEN Position: Q4 2022 in Review

Redhawk Wealth Advisors sold out of Repligen (RGEN) in Q4 2022, closing a stake of 7,079 shares — an estimated $1.32M sold.

Redhawk Wealth Advisors first reported a position in RGEN in Q2 2019 and held it in 14 quarters. The position peaked at $1.32M in Q3 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Redhawk Wealth Advisors reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 7,079 Repligen shares in Q4 2022, an estimated $1.32M.
  • Redhawk Wealth Advisors first reported a position in Repligen in Q2 2019 and held it in 14 quarters.
  • Redhawk Wealth Advisors's Repligen position peaked at $1.32M in Q3 2022.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Redhawk Wealth Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.